BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1312613)

  • 1. CArG, CCAAT, and CCAAT-like protein binding sites in avian retrovirus long terminal repeat enhancers.
    Zachow KR; Conklin KF
    J Virol; 1992 Apr; 66(4):1959-70. PubMed ID: 1312613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and defective components of avian endogenous virus long terminal repeat enhancer sequences.
    Habel DE; Dohrer KL; Conklin KF
    J Virol; 1993 Mar; 67(3):1545-54. PubMed ID: 8382309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
    Bowers WJ; Baglia LA; Ruddel A
    J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of an endogenous retrovirus enhancer by insertion into a heterologous context.
    Conklin KF
    J Virol; 1991 May; 65(5):2525-32. PubMed ID: 1850026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The VBP and a1/EBP leucine zipper factors bind overlapping subsets of avian retroviral long terminal repeat CCAAT/enhancer elements.
    Smith CD; Baglia LA; Curristin SM; Ruddell A
    J Virol; 1994 Oct; 68(10):6232-42. PubMed ID: 8083963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avian retroviral long terminal repeats bind CCAAT/enhancer-binding protein.
    Ryden TA; Beemon K
    Mol Cell Biol; 1989 Mar; 9(3):1155-64. PubMed ID: 2725492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of the C/EBP binding sites in the Rous sarcoma virus long terminal repeat and gag enhancers.
    Ryden TA; de Mars M; Beemon K
    J Virol; 1993 May; 67(5):2862-70. PubMed ID: 8386280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of EFIV, a stable factor present in many avian cell types that transactivates sequences in the 5' portion of the Rous sarcoma virus long terminal repeat enhancer.
    Houtz EK; Conklin KF
    J Virol; 1996 Jan; 70(1):393-401. PubMed ID: 8523553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning of Rous sarcoma virus enhancer factor genes. II. RSV-EF-II, abundantly expressed in fibroblasts and muscle tissue, binds to an octamer sequence, 5'-GTACCACC-3', in the noncoding strand of RSV enhancer.
    Cleavinger PJ; Shin BA; Kandala JC; Nambiar A; Swamynathan SK; Guntaka RV
    Virology; 1996 Aug; 222(1):133-43. PubMed ID: 8806494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning of Rous sarcoma virus enhancer factor genes. I. Evidence that RSV-EF-I is related to Y-box (inverted CCAAT) binding proteins and binds to multiple motifs in the RSV enhancer.
    Kandala JC; Guntaka RV
    Virology; 1994 Feb; 198(2):514-23. PubMed ID: 8291233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a third protein factor which binds to the Rous sarcoma virus LTR enhancer: possible homology with the serum response factor.
    Boulden A; Sealy L
    Virology; 1990 Jan; 174(1):204-16. PubMed ID: 2152992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activity of avian retroviral long terminal repeats directly correlates with enhancer activity.
    Cullen BR; Raymond K; Ju G
    J Virol; 1985 Feb; 53(2):515-21. PubMed ID: 2982034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing physiological variations in the activity of the Rous sarcoma virus long terminal repeat.
    Lang A; Fincham VJ; Wyke JA
    Virology; 1993 Oct; 196(2):564-75. PubMed ID: 8396803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximal serum stimulation of the c-fos serum response element requires both the serum response factor and a novel binding factor, SRE-binding protein.
    Boulden AM; Sealy LJ
    Mol Cell Biol; 1992 Oct; 12(10):4769-83. PubMed ID: 1328862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the transcription start site core region and transcription factor YY1 in Rous sarcoma virus long terminal repeat promoter activity.
    Mobley CM; Sealy L
    J Virol; 1998 Aug; 72(8):6592-601. PubMed ID: 9658104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rous sarcoma virus enhancer factor I is a ubiquitous CCAAT transcription factor highly related to CBF and NF-Y.
    Faber M; Sealy L
    J Biol Chem; 1990 Dec; 265(36):22243-54. PubMed ID: 2176209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activity of the Rous sarcoma virus long terminal repeat correlates with binding of a factor to an upstream CCAAT box in vitro.
    Greuel BT; Sealy L; Majors JE
    Virology; 1990 Jul; 177(1):33-43. PubMed ID: 2162108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of three sequence-specific DNA-binding proteins which interact with the Rous sarcoma virus enhancer and upstream promoter elements.
    Goodwin GH
    J Virol; 1988 Jun; 62(6):2186-90. PubMed ID: 2835519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence of the long terminal repeat and adjacent segments of the endogenous avian virus Rous-associated virus 0.
    Hughes SH
    J Virol; 1982 Jul; 43(1):191-200. PubMed ID: 6286997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and v-src increase the level of a CCAAT-binding factor required for transcription from a retroviral long terminal repeat.
    Dutta A; Stoeckle MY; Hanafusa H
    Genes Dev; 1990 Feb; 4(2):243-54. PubMed ID: 2159932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.